VLS-1272

1 1

Selleck Chemicals

E5992-1MG

€193,00 EUR
€193,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
View full details

VLS-1272 is an inhibitor of Kinesins used in studies of Cell Cycle Regulation. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to checkpoint control, mitotic progression, and proliferation timing in cancer and cell cycle models.

By inhibiting Kinesins, VLS-1272 can be used to examine checkpoint control, mitotic progression, and proliferation timing. This context is compatible with cell-cycle, mitotic, and proliferation assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In cancer and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving Kinesins
  • Pathway perturbation studies connected to Cell Cycle Regulation
  • Concentration-response inhibition and target-dependence studies
  • Phenotypic profiling in cancer and cell cycle models

Overall, VLS-1272 is appropriate when a defined chemical perturbant is needed to connect Kinesins with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
Kinesins
Target Class:
Other
Pathways:
Cell Cycle Regulation
Research Area:
Cancer • Cell Cycle
CAS No.:
2914878-00-3
Molecular Weight:
545.72
Formula:
C₂₇H₃₅N₃O₅S₂
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.